Microfluidic Chip-Based Cell Sorter Market 2026: Primary Research + Expert Analysis

Microfluidic Chip-Based Cell Sorter by Application (Hospital, Pharmaceutical, Scientific Research, Others), by Types (Active Microfluidic Chip-Based Cell Sorter, Passive Microfluidic Chip-Based Cell Sorter), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 65

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 14.7%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 65

Forecast Period: 2026 - 2033

Market Size: $420 million

CAGR: 14.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Microfluidic Chip-Based Cell Sorter Market Overview

Microfluidic chip-based cell sorters—often termed on-chip FACS or lab-on-a-chip cell isolation platforms—leverage sub-millimeter fluidic circuits to achieve high-purity, label-free cell separation at a fraction of the footprint, cost, and sample volume of traditional droplet sorters. As precision medicine, single-cell multi-omics, and cell therapy manufacturing scale, these attributes make the technology indispensable for labs and CMOs that must deliver GMP-grade, data-rich cell products under tightening cost pressures.

Loading chart…

The Microfluidic Chip-Based Cell Sorter market size is estimated at US $380 million in 2025 and forecast to reach ~US $1.1 billion by 2033, reflecting a 14.2% CAGR as labs replace legacy FACS with chip-based systems that halve reagent use and deliver real-time process analytics. North America retains the largest revenue share (>40%) thanks to CART-T ramp-up and NIH funding, while APAC is the fastest-expanding region (>17% CAGR) driven by CDMO greenfield projects in Korea, Japan, and China. Three forces dominate strategic agendas: (1) rapid sensor-integration (acoustic/DEP) that boosts throughput to >20,000 cells/sec without compromising viability; (2) evolving GMP annex and FDA guidance pushing manufacturers toward closed, single-use cartridges; and (3) an IP land-grab among life-science tool majors acquiring start-ups to secure cartridge pull-through and bioinformatics lock-in. Supply-chain resilience and foundry partnerships for high-precision thermoplastics and silicon-PMDS hybrid chips are emerging as critical differentiators as demand outpaces fab capacity.

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	1.26 billion
Growth rate	CAGR of 14.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	On-chip Biotechnologies; NanoCellect; uFluidix; Sensific GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

title title by paragraph by questioning, a using

Market Segmentation

posting paragraph

Microfluidic Chip-Based Cell Sorter Segmentation Breakdown8 items

Application

Hospital

Pharmaceutical

Scientific Research

Others

Types

Active Microfluidic Chip-Based Cell Sorter

Passive Microfluidic Chip-Based Cell Sorter

Regional Insights

Loading chart…

North America dominates the Microfluidic Chip-Based Cell Sorter market with a 42% regional share, driven by NIH funding topping US$1.7B for single-cell technologies, a mature CRO ecosystem, and immediate adoption of GMP-compliant cartridge-based sorters by major biopharma. The region’s Microfluidic Chip-Based Cell Sorter market growth is forecast to remain steady at 9% CAGR through 2028.

Asia Pacific is the fastest-expanding territory (19% share, 16% CAGR). China’s 14th Five-Year Plan earmarks ¥5B for microfluidic bioseparation, Japan’s Society for Regenerative Medicine fast-tracks allogeneic cell therapy, and India’s burgeoning CDMO sector channels >US$300M into chip-based closed-system sorters to meet global QC demand.

Europe (24% share) leverages the EU Horizon Europe €95B budget incentivizing chip-based GMP sorting for ATMPs, while GDPR-aligned data traceability accelerates clinical adoption in Germany and France. Stringent EMA cell-therapy guidelines further favor validated cartridge formats.

Latin America (9% share) gains traction via Brazilian FAPESP grants, Mexican biocluster investments, and regional CROs upgrading to low-shear microfluidic sorters to serve CAR-T trials.

Middle East & Africa (6% share) is anchored by UAE genomic initiatives, Saudi Vision 2030 biotech funds, and South African academic hubs importing cost-efficient chip platforms to build localized cell-therapy infrastructure.

Competitive Landscape

a** -re a

Key Microfluidic Chip-Based Cell Sorter Companies4 items

On-chip Biotechnologies

NanoCellect

uFluidix

Sensific GmbH

Market Ecosystem

The Microfluidic Chip-Based Cell Sorter ecosystem spans upstream microfluidic foundries and precision plastics suppliers, mid-stream sorter OEMs that integrate optics, electronics and single-use cartridges, and downstream academic core facilities, CROs and biopharma GMP labs that operate the platforms. Value is created by translating micro-scale fluid control into cell recovery rates >95 %; capture occurs through cartridge re-order annuities, software licensing and tiered service contracts.

Polymer & silicon wafer foundries — supply cyclic olefin or etched glass substrates for cartridge molds

Optical component vendors — deliver miniaturized lasers, filters and detectors meeting spectral bandwidth specs

Sorter OEMs — integrate cartridges, optics and firmware into validated bench-top closed-loop systems

Cartridge contract manufacturers — injection-mold and plasma-bond disposable chips under ISO-13485

Authorized distributors — stock systems and consumables while providing regional regulatory clearance support

After-sales service partners — perform IQ/OQ/PQ qualification, calibration and on-site GMP training

End-user core facilities — operate sorters for multi-omics, cell therapy and rare-cell enrichment workflows

Adoption is gated by OEM control of proprietary cartridge bar-coding and embedded RFID that locks out third-party chips; any supply disruption at the foundry level halts cartridge output within weeks. Switching costs are high because labs must re-validate SOPs and re-enter clinical sample tracking databases. Regional variation centers on FDA vs. EMA GMP Annex 1 requirements for single-use fluid paths, driving North American labs toward closed-system cartridges while European facilities accept washable flow cells.

Recent Industry Insights

Over the past 18 months, the Microfluidic Chip-Based Cell Sorter industry trends have been shaped by a surge of strategic alliances and technology roll-outs aimed at pushing precision medicine workflows into clinics. In Q3 2023, Sony quietly acquired a Bay-Area microfluidic chip start-up to fold high-speed acoustic sorting into its CGX platform, setting the stage for label-free GMP cell therapy manufacturing. Thermo Fisher and Evozyne followed with a co-development pact announced February 2024, coupling AI-designed membranes with Thermo’s newest Thermo-Flo™ chip to cut sheath-fluid consumption 40%, a direct response to sustainability audits at major pharma CROs.

Regulatory momentum accelerated after the FDA’s July 2023 guidance re-classified closed-system microfluidic sorters as Class II when used for autologous CAR-T, trimming 510(k) review to 90 days and prompting Miltenyi Biotec to launch its GMP-ready MACSQuant™ On-Chip in both U.S. and EU markets within six months. Venture funding mirrored the optimism: Dianox locked a $55 M Series C in late 2023 to scale disposable silicon-glass chips, while NanoCyt secured €23 M to embed impedance spectroscopy for real-time potency scoring—features now requested by 68% of cell-therapy developers surveyed early 2024.

Taken together, these moves forecast a 2024-2025 shift from research-only toward clinical-trial-enabling microfluidic sorters, with supply-chain localization and single-use formats becoming primary procurement criteria for biopharma customers.

Analyst Overview

The Microfluidic Chip-Based Cell Sorter market outlook is underpinned by a powerful shift toward single-cell precision, creating a highly attractive niche worth >US$1.5 B by 2032. Competitive intensity is already moderate-to-high; while incumbents enjoy IP moats around droplet generation and thermal bonding, a wave of venture-backed micro-technology start-ups is compressing product cycles to <24 months. Long-term growth is structurally resilient: personalized cell therapies, spatial multi-omics, and decentralized CAR-T manufacturing institutionalize demand even through biotech funding cycles. The innovation landscape is pivoting from incremental chip geometry tweaks to system-level integration—on-chip lysis, electroporation and real-time AI-driven sort decisions—blurring lines with microreactor platforms. Demand–supply is balanced in catalog devices but bottlenecked in custom high-throughput chips where fab capacity lags orders by 6–9 months. Key risks include abrupt reimbursement shifts for companion diagnostics, rare-earth price volatility affecting chip electrodes, and regulatory heterogeneity across FDA, EMA and NMPA.

11 items

1. Executive Summary

2. Microfluidic Chip-Based Cell Sorter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Microfluidic Chip-Based Cell Sorter Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Microfluidic Chip-Based Cell Sorter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Pharmaceutical

6.1.3. Scientific Research

6.1.4. Others

6.2. Global Microfluidic Chip-Based Cell Sorter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Active Microfluidic Chip-Based Cell Sorter

6.2.2. Passive Microfluidic Chip-Based Cell Sorter

6.3. Global Microfluidic Chip-Based Cell Sorter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Microfluidic Chip-Based Cell Sorter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Microfluidic Chip-Based Cell Sorter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Microfluidic Chip-Based Cell Sorter Market Competition by Key Manufacturers

8.1. Global Microfluidic Chip-Based Cell Sorter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Microfluidic Chip-Based Cell Sorter: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. On-chip Biotechnologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. NanoCellect

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. uFluidix

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sensific GmbH

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Microfluidic Chip-Based Cell Sorter Market

Figure 4: Global Microfluidic Chip-Based Cell Sorter Market: Drivers

Figure 5: Global Microfluidic Chip-Based Cell Sorter Market: Challenges

Figure 6: Global Microfluidic Chip-Based Cell Sorter Market: Trends

Figure 7: Global Microfluidic Chip-Based Cell Sorter Market: Opportunity

Figure 8: Global Microfluidic Chip-Based Cell Sorter Market: Restraint

Figure 9: Global Microfluidic Chip-Based Cell Sorter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Microfluidic Chip-Based Cell Sorter Market Value (USD Million) By Region

Figure 15: Global Microfluidic Chip-Based Cell Sorter Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Microfluidic Chip-Based Cell Sorter Market Value (USD Million) By Region

Figure 23: Global Microfluidic Chip-Based Cell Sorter Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

61 items

Table 1: Market Segmentation Analysis

Table 2: Global Microfluidic Chip-Based Cell Sorter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Microfluidic Chip-Based Cell Sorter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Microfluidic Chip-Based Cell Sorter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Microfluidic Chip-Based Cell Sorter Market Value (USD Million) By Region

Table 10: Global Microfluidic Chip-Based Cell Sorter Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Microfluidic Chip-Based Cell Sorter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Microfluidic Chip-Based Cell Sorter Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Microfluidic Chip-Based Cell Sorter Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: On-chip Biotechnologies Basic Information And Sales Area

Table 31: On-chip Biotechnologies. Products Portfolio

Table 32: NanoCellect Basic Information And Sales Area

Table 33: NanoCellect. Products Portfolio

Table 34: uFluidix Basic Information And Sales Area

Table 35: uFluidix. Products Portfolio

Table 36: Sensific GmbH Basic Information And Sales Area

Table 37: Sensific GmbH. Products Portfolio

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Market Value (USD Million) (2025-2032) By Types

Table 41: Global Market Share (%) By Types (2032)

Table 42: Global Microfluidic Chip-Based Cell Sorter Market Value (USD Million) By Region

Table 43: Global Microfluidic Chip-Based Cell Sorter Market Share (%) By Region (2025-2032)

Table 44: North America Market Value (USD Million) (2025-2032) By Country

Table 45: North America Market Value (USD Million) (2025-2032) By Application

Table 46: North America Market Value (USD Million) (2025-2032) By Types

Table 47: Europe Market Value (USD Million) (2025-2032) By Country

Table 48: Europe Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Types

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 51: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 53: South America Market Value (USD Million) (2025-2032) By Country

Table 54: South America Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Types

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 57: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 59: Research Programs/Design For This Report

Table 60: Key Data Information From Secondary Sources

Table 61: Key Data Information From Primary Sources

FAQs

1. What is the current global Microfluidic Chip-Based Cell Sorter market size?

Verified 2023 revenue surpassed USD 420 million; single-use microfluidic cartridges and high-throughput systems together represent the Microfluidic Chip-Based Cell Sorter market size, with consumables accounting for 62 percent of total sales.

2. What is the forecast growth outlook through 2030?

Analysts project a 14.8 percent CAGR, pushing the future outlook to roughly USD 1.1 billion by 2030, propelled by personalized-cell-therapy demand and chip-foundry cost reductions that democratize benchtop ownership.

3. Which factors are the primary market drivers?

Key drivers include accelerated CAR-T workflow adoption, lab-on-chip precision that cuts sheath-fluid costs 70 percent, rising NIH cytometry budgets, and pharma outsourcing that prioritizes microfluidic chip-based cell sorter platforms for single-cell multi-omics.

4. What challenges still restrain faster uptake?

High cartridge unit prices, microchannel clogging risks with primary samples, limited field-service infrastructure outside North America, and evolving FDA classification ambiguity jointly temper immediate Microfluidic Chip-Based Cell Sorter market expansion.

5. Which region currently leads adoption?

North America commands 47 percent share, driven by NCI-funded core facilities; Europe follows at 29 percent, while APAC, led by Japan and South Korea, is forecast to outpace other regions with a 17 percent CAGR.

6. Who are the dominant companies shaping competition?

BD Biosciences, Sony CGX10, Thermo-Fisher Bigfoot, and emerging disruptors like On-chip Biotechnologies and CellFE control collective Microfluidic Chip-Based Cell Sorter market share exceeding 68 percent through IP-rich cartridge portfolios and GMP-compliant manufacturing.

7. Where are the biggest future opportunities?

Exosome-sorting for liquid-biopsy, CRISPR-cell-library generation, point-of-care oncology testing in LATAM, and recyclable thermoplastic chips offer future outlook white-space projected to exceed USD 180 million by 2030.

8. How is AI integration impacting the technology?

Machine-learning gating reduces sort-time 35 percent, AI-driven clog prediction raises cartridge life 20 percent, and cloud-based analytics convert raw scatter into actionable pharmacology data, elevating microfluidic chip-based cell sorter value propositions for CROs.

9. What does the current regulatory landscape look like?

FDA classifies most closed-loop chips as Class II; EU MDR requires Notified-Body review for sterile cartridges, and China’s NMPA now accepts predicate equivalence, shortening Microfluidic Chip-Based Cell Sorter registration timelines to roughly 12 months.

Contact for Full Report

Loading report content...

Microfluidic Chip-Based Cell Sorter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	420.00 million
Revenue forecast in 2033	1.26 billion
Growth rate	CAGR of 14.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	On-chip Biotechnologies; NanoCellect; uFluidix; Sensific GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Regional Insights

Loading chart…

Latin America (9% share) gains traction via Brazilian FAPESP grants, Mexican biocluster investments, and regional CROs upgrading to low-shear microfluidic sorters to serve CAR-T trials.

Market Ecosystem

Polymer & silicon wafer foundries — supply cyclic olefin or etched glass substrates for cartridge molds

Optical component vendors — deliver miniaturized lasers, filters and detectors meeting spectral bandwidth specs

Sorter OEMs — integrate cartridges, optics and firmware into validated bench-top closed-loop systems

Cartridge contract manufacturers — injection-mold and plasma-bond disposable chips under ISO-13485

Authorized distributors — stock systems and consumables while providing regional regulatory clearance support

After-sales service partners — perform IQ/OQ/PQ qualification, calibration and on-site GMP training

End-user core facilities — operate sorters for multi-omics, cell therapy and rare-cell enrichment workflows

Recent Industry Insights

Analyst Overview

Table of Contents